Departing Teva Exec Issues Warnings On Popular Shortage Solutions
Before leaving her role as Teva’s US generics COO, Christine Baeder discussed paying for quality, generic confidence, redundancy and predicting shortages.

Before leaving her role as Teva’s US generics COO, Christine Baeder discussed paying for quality, generic confidence, redundancy and predicting shortages.